CU06-1004-Induced Vascular Normalization Improves Immunotherapy by Modulating Tumor Microenvironment via Cytotoxic T Cells

CU06-1004-Induced Vascular Normalization Improves Immunotherapy by Modulating Tumor Microenvironment via Cytotoxic T Cells

Blocking the immune evasion mechanism of tumor cells has become an attractive means for treating cancers. However, the usage of a drug such as nivolumab (αPD-1), which blocks programmed cell death protein 1 (PD-1), turned out to be only effective against certain types of cancer. Especially, vascular...

Full description

Bibliographic Details
Main Authors:	Songyi Park, Ji Hoon Oh, Dong Jin Park, Haiying Zhang, Minyoung Noh, Yeomyung Kim, Ye-Seul Kim, Hyejeong Kim, Young-Myeong Kim, Sang-Jun Ha, Young-Guen Kwon
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-01-01
Series:	Frontiers in Immunology
Subjects:	CU06-1004 anti-PD-1 combination therapy drug delivery tumor microenvironment (TME) immune checkpoint blockade (ICB)
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2020.620166/full

Similar Items

CU06-1004 Alleviates Experimental Colitis by Modulating Colonic Vessel Dysfunction
by: Ye-Seul Kim, et al.
Published: (2020-09-01)

Efficacy of CU06-1004 via regulation of inflammation and endothelial permeability in LPS-induced acute lung injury
by: Yeomyeong Kim, et al.
Published: (2023-04-01)

Long-term administration of CU06-1004 ameliorates cerebrovascular aging and BBB injury in aging mouse model
by: Hyejeong Kim, et al.
Published: (2023-02-01)

Development of Biofungicide Using Bacillus sp. KBC1004 for the Control of Anthracnose of Red Pepper
by: Hoon-Serg Kang, et al.
Published: (2015-09-01)

Sac-1004, a vascular leakage blocker, reduces cerebral ischemia—reperfusion injury by suppressing blood–brain barrier disruption and inflammation
by: Haiying Zhang, et al.
Published: (2017-06-01)

CU06-1004 as a promising strategy to improve anti-cancer drug efficacy by preventing vascular leaky syndrome
by: Songyi Park, et al.
Published: (2023-08-01)

Trauma and Adolescents
by: Ashley Eckes, et al.
Published: (2007-11-01)

Chaconne BWV 1004 de J.S. Bach na transcrição de Andrés Segovia e sua ênfase acordal para uma proposta sonora robusta: análise comparativa da primeira seção
by: Christhian Barcelos Carvalho Lima Beschizza, et al.
Published: (2016-10-01)

A Comprehensive Benchmark of Transcriptomic Biomarkers for Immune Checkpoint Blockades
by: Hongen Kang, et al.
Published: (2023-08-01)

PCSK9 facilitates melanoma pathogenesis via a network regulating tumor immunity
by: Yan Gu, et al.
Published: (2023-01-01)

Immune checkpoint inhibition mediated with liposomal nanomedicine for cancer therapy
by: Guang-Long Ma, et al.
Published: (2023-04-01)

Immunotherapy of targeting MDSCs in tumor microenvironment
by: Hongshu Sui, et al.
Published: (2022-09-01)

Primaquine Diphosphate, a Known Antimalarial Drug, Blocks Vascular Leakage Acting Through Junction Stabilization
by: Minyoung Noh, et al.
Published: (2021-06-01)

Absorption, Metabolism, and Excretion of ACT-1004-1239, a First-In-Class CXCR7 Antagonist: In Vitro, Preclinical, and Clinical Data
by: Christine Huynh, et al.
Published: (2022-03-01)

From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma
by: Yaojie Fu, et al.
Published: (2019-09-01)

Immune responses to SARS-CoV-2 in vaccinated patients receiving checkpoint blockade immunotherapy for cancer
by: Alexander Piening, et al.
Published: (2022-12-01)

Overexpression of SMS in the tumor microenvironment is associated with immunosuppression in hepatocellular carcinoma
by: Lin Xiang, et al.
Published: (2022-12-01)

Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment
by: Zhifei Gao, et al.
Published: (2023-02-01)

Review immune response of targeting CD39 in cancer
by: Yao Liu, et al.
Published: (2023-06-01)

Radiotherapy induced immunogenic cell death by remodeling tumor immune microenvironment
by: Songxin Zhu, et al.
Published: (2022-12-01)

Tuning the Tumor Myeloid Microenvironment to Fight Cancer
by: Nadine S. Jahchan, et al.
Published: (2019-07-01)

Editorial: Optimized gene-engineering and combination therapies to boost γδT cell immunotherapeutic performance
by: Marta Barisa, et al.
Published: (2024-04-01)

Strategies for improving the performance of prediction models for response to immune checkpoint blockade therapy in cancer
by: Tiantian Zeng, et al.
Published: (2024-04-01)

Systematic Assessment of Transcriptomic Biomarkers for Immune Checkpoint Blockade Response in Cancer Immunotherapy
by: Shangqin Sun, et al.
Published: (2021-04-01)

Combinational Immunotherapy for Hepatocellular Carcinoma: Radiotherapy, Immune Checkpoint Blockade and Beyond
by: Yun Hua Lee, et al.
Published: (2020-09-01)

Safety of Interchanging the Live Attenuated MAV/06 Strain and OKA Strain Varicella Vaccines in Children
by: Hyun Mi Kang, et al.
Published: (2023-08-01)

The Chemokines Initiating and Maintaining Immune Hot Phenotype Are Prognostic in ICB of HNSCC
by: Yuhong Huang, et al.
Published: (2022-05-01)

LSD1: an emerging face in altering the tumor microenvironment and enhancing immune checkpoint therapy
by: M A A Mamun, et al.
Published: (2023-07-01)

Predictive value of PIMREG in the prognosis and response to immune checkpoint blockade of glioma patients
by: Hua Zhu, et al.
Published: (2022-07-01)

A novel small molecule, CU05-1189, targeting the pleckstrin homology domain of PDK1 suppresses VEGF-mediated angiogenesis and tumor growth by blocking the Akt signaling pathway
by: Jeongeun Park, et al.
Published: (2023-11-01)

Crosstalk between G protein-coupled receptors (GPCRs) and tyrosine kinase receptor (TXR) in the heart after morphine withdrawal
by: Pilar eAlmela, et al.
Published: (2013-12-01)

Drug-loaded microbubble delivery system to enhance PD-L1 blockade immunotherapy with remodeling immune microenvironment
by: Jun Zheng, et al.
Published: (2023-02-01)

Identification of Neoantigens in Cancer Cells as Targets for Immunotherapy
by: Masahiro Okada, et al.
Published: (2022-02-01)

The endothelial dysfunction blocker CU06-1004 ameliorates choline-deficient L-amino acid diet-induced non-alcoholic steatohepatitis in mice.
by: Cho-Rong Bae, et al.
Published: (2020-01-01)

The implications of clinical risk factors, CAR index, and compositional changes of immune cells on hyperprogressive disease in non-small cell lung cancer patients receiving immunotherapy
by: Seo Ree Kim, et al.
Published: (2021-01-01)

Molecular basis, potential biomarkers, and future prospects of OSCC and PD-1/PD-L1 related immunotherapy methods
by: Yuxi Cheng, et al.
Published: (2024-02-01)

Monoclonal Antibodies in Cancer Therapy
by: David Zahavi, et al.
Published: (2020-07-01)

The antihypertensive felodipine shows synergistic activity with immune checkpoint blockade and inhibits tumor growth via NFAT1 in LUSC
by: Liang Si-Yu, et al.
Published: (2023-09-01)

Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade
by: Baoyuan Zhang, et al.
Published: (2024-02-01)

Immunotherapy in endometrial cancer: rationale, practice and perspectives
by: Wenyu Cao, et al.
Published: (2021-06-01)